Immunopotentiating Role of IFN-γ in Early and Late Stages of Type 1 CD8 Effector Cell-Mediated Tumor Rejection
- 31 January 2001
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 98 (1), 70-84
- https://doi.org/10.1006/clim.2000.4945
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The Role of CCR7 in T H 1 and T H 2 Cell Localization and Delivery of B Cell Help in VivoScience, 1999
- Interferon γ Induces the Expression of p21waf-1 and Arrests Macrophage Cell Cycle, Preventing Induction of ApoptosisImmunity, 1999
- Tumor Cell Responses to IFNγ Affect Tumorigenicity and Response to IL-12 Therapy and AntiangiogenesisImmunity, 1998
- T CELL MEMORYAnnual Review of Immunology, 1998
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- Recent Advances in the Care of the Patient with Malignant MelanomaAnnals of Surgery, 1997
- Wild-type p53-induced apoptosis in a Burkitt lymphoma cell line is inhibited by interferon gammaInternational Journal of Cancer, 1996
- Evidence that Granulocyte/Macrophage-Colony-Stimulating Factor and Interferon-γ Maintain the Viability of Human Peripheral Blood Monocytes in Part by Their Suppression of IL-10 ProductionInternational Archives of Allergy and Immunology, 1995
- T cell receptor antagonist peptides induce positive selectionCell, 1994
- Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1993